Feature

Enthesitis, arthritis, tenosynovitis linked to dupilumab use for atopic dermatitis

Publish date: June 1, 2023

 

FROM ARTHRITIS & RHEUMATOLOGY

A version of this article first appeared on Medscape.com.

Pages

Recommended Reading

Air pollution may be causing eczema
Federal Practitioner
Topical delgocitinib shows promise for chronic hand eczema, pivotal trial shows
Federal Practitioner
JAK inhibitor ivarmacitinib shows efficacy for atopic dermatitis in a pivotal trial
Federal Practitioner
What are the clinical implications of recent skin dysbiosis discoveries?
Federal Practitioner
Can this tool forecast peanut allergies?
Federal Practitioner
Facial, hand, and foot dermatitis: Lebrikizumab and dupilumab show efficacy in new studies
Federal Practitioner
Expunging ‘penicillin allergy’: Your questions answered
Federal Practitioner
AD in infancy: Diagnostic advice and treatment tips
Federal Practitioner
Can online mindfulness and self-compassion training improve quality of life for patients with atopic dermatitis?
Federal Practitioner
JAK-inhibitor safety in adolescents with AD: Long-term analyses reported
Federal Practitioner